4) Adjuvants and immune stimulants: The combination of a DNA vaccine containing a fusion gene of MUC1 and VEGFR2, along with the use of GM-CSF as an adjuvant showed an increased inhibition in the growth of MUC1-expressing tumours and prolonged mouse survival (335). The gene discussed is MUC1; the disease is neoplasm.